相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects
Patrick Vizeli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
Patrick C. Dolder et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Effects of d-amphetamine upon psychosocial stress responses
Emma Childs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting
Matthew J. Baggott et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
Anya K. Bershad et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy
Timothy Amoroso et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Neuroimaging in moderate MDMA use: A systematic review
F. Mueller et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals
Yasmin Schmid et al.
PHARMACOGENETICS AND GENOMICS (2016)
Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective
Kim P. C. Kuypers et al.
PLOS ONE (2016)
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
Michael C. Mithoefer et al.
LANCET PSYCHIATRY (2016)
MDMA-Induced Acute Liver Failure and Transient Abdominal Pneumatosis
Ritesh Maharaj et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Making a medicine out of MDMA
Ben Sessa et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Human pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart
Magi Farre et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Effects of Acute Doses of Prosocial Drugs Methamphetamine and Alcohol on Plasma Oxytocin Levels
Anya K. Bershad et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals
Philip Kamilar-Britt et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects
Yasmin Schmid et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases
Ruud P. W. Litjens et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
A reconsideration and response to Parrott AC (2013) Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research
Rick Doblin et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories
R. L. Carhart-Harris et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination
Cedric M. Hysek et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Differential effects of MDMA and methylphenidate on social cognition
Yasmin Schmid et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Memory and mood during MDMA intoxication, with and without memantine pretreatment
E. B. de Sousa Fernandes Perna et al.
NEUROPHARMACOLOGY (2014)
Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing
Matthew G. Kirkpatrick et al.
NEUROPSYCHOPHARMACOLOGY (2014)
No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation
Kim P. C. Kuypers et al.
PLOS ONE (2014)
MDMA effects consistent across laboratories
Matthew G. Kirkpatrick et al.
PSYCHOPHARMACOLOGY (2014)
Can ecstasy treat the agony of PTSD?
Kai Kupferschmidt
SCIENCE (2014)
MDMA enhances emotional empathy and prosocial behavior
Cedric M. Hysek et al.
SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE (2014)
'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content
Margaret C. Wardle et al.
SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE (2014)
The Potential Dangers of Using MDMA for Psychotherapy
Andrew C. Parrott
JOURNAL OF PSYCHOACTIVE DRUGS (2014)
Pharmacological characterization of designer cathinones in vitro
L. D. Simmler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Human psychobiology of MDMA or Ecstasy': an overview of 25years of empirical research
Andrew C. Parrott
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
α1-Adrenergic Receptors Contribute to the Acute Effects of 3,4-Methylenedioxymethamphetamine in Humans
Cedric M. Hysek et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
A randomized, controlled pilot study of MDMA (+/- 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)
Peter Oehen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users
Andrew C. Parrott
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart
A. M. Peiro et al.
PSYCHOPHARMACOLOGY (2013)
Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans
C. M. Hysek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Duloxetine Inhibits Effects of MDMA (Ecstasy) In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study
Cedric M. Hysek et al.
PLOS ONE (2012)
Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT2 and 5-HT1 Receptors
Janelle H. P. van Wel et al.
PLOS ONE (2012)
Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy''): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
Ricardo Pardo-Lozano et al.
PLOS ONE (2012)
A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans
Matthew G. Kirkpatrick et al.
PSYCHOPHARMACOLOGY (2012)
Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users
Tibor M. Brunt et al.
PSYCHOPHARMACOLOGY (2012)
Effects of amphetamine on reactivity to emotional stimuli
Margaret C. Wardle et al.
PSYCHOPHARMACOLOGY (2012)
Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex
Cedric M. Hysek et al.
PSYCHOPHARMACOLOGY (2012)
MDMA enhances mind reading of positive emotions and impairs mind reading of negative emotions
Cedric M. Hysek et al.
PSYCHOPHARMACOLOGY (2012)
Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior
Margaret C. Wardle et al.
PSYCHOPHARMACOLOGY (2012)
Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
Cedric M. Hysek et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (Ecstasy) in Humans
C. M. Hysek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions
Pinchas Halpern et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2011)
Sex Differences in the Effects of MDMA (Ecstasy) on Plasma Copeptin in Healthy Subjects
Linda D. Simmler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The safety and efficacy of ± 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study
Andrew C. Parrott et al.
PSYCHOPHARMACOLOGY (2011)
Is Ecstasy an Empathogen? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others
Gillinder Bedi et al.
BIOLOGICAL PSYCHIATRY (2010)
Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology
G. J. H. Dumont et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Cannabis Coadministration Potentiates the Effects of Ecstasy on Heart Rate and Temperature in Humans
G. J. Dumont et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA
F. Hasler et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration
Erin A. Kolbrich et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Plasma pharmacokinetics of 3.4-methylenedioxymethamphetamine after controlled oral administration to young adults
Erin A. Kolbrich et al.
THERAPEUTIC DRUG MONITORING (2008)
Pharmacological interaction between 3,4-methylenedioxymethamphetamine (Ecstasy) and paroxetine:: Pharmacological effects and pharmacokinetics
Magi Farre et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Patterns of ecstasy-associated hyponatremia in California
Jonathan Rosenson et al.
ANNALS OF EMERGENCY MEDICINE (2007)
The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review
A. C. Parrott
PSYCHOPHARMACOLOGY (2007)
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
GJH Dumont et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
RR Freedman et al.
PSYCHOPHARMACOLOGY (2005)
Repeated doses administration of MDMA in humans:: pharmacological effects and pharmacokinetics
M Farré et al.
PSYCHOPHARMACOLOGY (2004)
'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting
Ron Ben-Abraham et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2003)
Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP
M Tancer et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion
TK Hartung et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2002)
Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) on mood:: evidence of gender differences
SL Verheyden et al.
PSYCHOPHARMACOLOGY (2002)
Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons
L Reneman et al.
LANCET (2001)
Gender differences in the subjective effects of MDMA
ME Liechti et al.
PSYCHOPHARMACOLOGY (2001)
分享论文
